Trial Profile
A Randomized Double Blind Placebo Controlled Study of Intravenous Immunoglobulin (IVIG) Patients With Voltage Gated Potassium Channel Complex (VGKC) Antibody Associated Autoimmune Epilepsy
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs Immune globulin (Primary)
- Indications Epilepsy
- Focus Therapeutic Use
- 04 Dec 2018 Status changed from recruiting to discontinued.
- 09 Mar 2016 New trial record